Myc is known to induce apoptosis by repressing the activity of Bcl-XL, an anti-apoptotic factor of BCL-2 family; mice expressing Myc and Bcl-XL developed plasma cell tumors with a higher incidence rate and shorter onset time than single transgenic Myc mice [7]. Here, BCL2L1 is linked to plasma cell neoplasm.